Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Papillary carcinoma.

A L Vickery, M L Carcangiu, J V Johannessen

    Seminars in Diagnostic Pathology
    |May 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    This study clarifies diagnostic criteria for papillary thyroid carcinoma, emphasizing nuclear features and tumor size for accurate classification. Consensus was reached on classifying mixed tumors and recognizing specific morphological variants for improved diagnosis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Development of a pediatric differentiated thyroid carcinoma registry within the EuRRECa project: rationale and protocol.

    Endocrine connections·2023
    Same author

    Cribriform-morular variant of thyroid carcinoma.

    Pathologica·2019
    Same author

    Corrigendum to ``Survey of gynecological carcinosarcomas in families with breast and ovarian cancer predisposition'' [Cancer Genet. 221(2018) 38-45].

    Cancer genetics·2018
    Same author

    Sentinel node biopsy after primary chemotherapy in cT2 N0/1 breast cancer patients: Long-term results of a retrospective study.

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2017
    Same author

    EWSR1 rearrangement is a frequent event in papillary thyroid carcinoma and in carcinoma of the thyroid with Ewing family tumor elements (CEFTE).

    Virchows Archiv : an international journal of pathology·2017
    Same author

    GLUT1, MCT1/4 and CD147 overexpression supports the metabolic reprogramming in papillary renal cell carcinoma.

    Histology and histopathology·2016

    Area of Science:

    • Endocrinology
    • Pathology
    • Oncology

    Background:

    • Accurate diagnosis of papillary thyroid carcinoma is crucial for effective patient management.
    • Variability in diagnostic criteria can lead to inconsistent classifications and prognoses.

    Purpose of the Study:

    • To establish consensus on diagnostic criteria for papillary thyroid carcinoma.
    • To review illustrative cases and identify areas of agreement among experts.

    Main Methods:

    • Review of workshop discussions on illustrative cases of papillary thyroid carcinoma.
    • Analysis of expert consensus on histological and cytological features.

    Main Results:

    • Consensus on classifying mixed papillary-follicular carcinomas as papillary.

    Related Experiment Videos

  • Identification of three morphological variants: follicular, encapsulated, and diffuse sclerosing.
  • Nuclear features (N/C ratio, outline irregularity, pale staining) cited as key diagnostic criteria.
  • Gross tumor extent as the most valuable prognostic indicator.
  • Definition of small carcinomas by size, avoiding the term 'occult'.

    • Conclusions:

    • A combination of histological features, particularly nuclear characteristics, is essential for diagnosing papillary thyroid carcinoma.
    • Tumor size and gross extent are more reliable for prognosis than current grading systems.
    • Thyroglobulin is a reliable marker, while keratin is not specific for differentiating papillary from follicular carcinomas.